Regulatory30 May 2026, 06:21 pm
Continental Chemicals: Deviation Statement for March 2026 Quarter
AI Summary
Continental Chemicals Ltd. has filed a statement of deviation and variation in the utilization of funds raised through a preferential issue for the quarter ended March 31, 2026, as per Regulation 32 of SEBI (LODR) Regulations, 2015. The company raised ₹1,62,50,000 through preferential issues on 14/10/2019, intended for working capital. The audit committee reviewed and approved the statement. The funds were fully utilized by the quarter ended 31/12/2023, with no deviation or variation reported for the current quarter.
Key Highlights
- Continental Chemicals reports no deviation in fund utilization for Q4 2026.
- Funds raised through preferential issue were fully utilized by Dec 31, 2023.
- The funds, amounting to ₹1,62,50,000, were allocated for working capital.
- Audit Committee reviewed and approved the statement of deviation.
- Report filed as per SEBI (LODR) Regulations, 2015, Regulation 32.
Price Impact
More from CONTCHM